ACBP/DBI Protein Emerges as Key Target for Liver Disease Prevention and Treatment
New research reveals how neutralizing ACBP/DBI protein could prevent and treat fatty liver disease, fibrosis, and liver cancer through autophagy restoration.
3442 articles
New research reveals how neutralizing ACBP/DBI protein could prevent and treat fatty liver disease, fibrosis, and liver cancer through autophagy restoration.
Researchers discover that neutralizing ACBP protein reduces joint inflammation and cartilage damage in osteoarthritis models.
Researchers propose using partial reprogramming to rejuvenate donor organs outside the body before transplantation.
Researchers identify methods to induce powerful regenerative cell clusters in mammals using temporary pluripotency factors.
Scientists discover how reprogramming factors rejuvenate eye cells and restore vision by activating a protective enzyme that clears toxic lipids.
Meta-analysis of 106,395 patients reveals GLP-1 receptor agonists increase risk of gallstones by 46% and GERD by 119%.
New research reveals how obesity triggers chronic inflammation and how GLP-1 medications provide anti-inflammatory benefits independent of weight loss.
New research explores how GLP-1-based drugs like Ozempic and Wegovy work to treat obesity beyond simple appetite suppression.
New research reveals structural brain changes in the hypothalamus of adults with narcolepsy type 1.
Longitudinal study of 231 women shows sleep disruption drives perinatal anxiety, not the reverse, suggesting sleep as modifiable target.
Researchers develop AI-powered approach to improve diagnosis of obstructive sleep apnea in babies using oxygen monitoring.
New technique uses cerebrospinal fluid to decode methylation signatures in children's brain tumors, potentially improving diagnosis.